/_media/adv/web/images/2010/20100702_Midmark_AR-300x250.jpg

Subscriptions

Advertising

Resources

About Us

Contact Us

Create An Account Forgot Your Password?
Trouble logging in or creating an account? click here
Home This Month E-Weekly Newsletter Building a Facility Article Archive Second Opinions
Search:
Benchmarking
General Surgery
Accrediting/Quality
Anesthesia
Code/Bill/Reimburse
Building/Renovating
/_media/adv/web/images/2010/20100126_ImageFirst_LB-154x100.gif
/_media/adv/web/images/2010/20100511_Arthrex_LB_154x100.gif
/_media/adv/web/images/2010/20100407_ORX_LB-01_154x100.gif
Outpatient Surgery E-Weekly

News & Notes

Tip of the week Are red-bag wastes, sharps, recyclables and unshredded sensitive paperwork routinely ending up in your regular trash bins? Line those ...

InstaPoll: Do You Check Your Work E-Mail on Vacation?

Be honest: When you're on vacation, do you feel compelled to check your work e-mail 2 or 3 or 4 times a day? Or do you manage to leave it all behind...

N.Y. Hepatitis Outbreaks Linked to Propofol Reuse

An investigation into a pair of hepatitis outbreaks in New York City has revealed that the same anesthesiologist was responsible for spreading 6 cas...

Home > News > November, 2008

AMO Voluntarily Recalls Healon D

Company says it has received "limited reports" of inflammatory reaction.

After receiving reports that a few U.S. physicians observed an inflammatory reaction in some patients at the one-day post-operative visit, Advanced Medical Optics is voluntarily recalling a specific lot number of Healon D viscoelastic.

  • Product code: 10204011

  • Description: 30mg/mL, 0.65 mL fill size

  • Lot number: UD30654

    This lot is being recalled because endotoxin levels above specification have been noted in some syringes tested, says AMO in a recall letter. Endotoxin levels above the maximum USP level may be potential causes of an inflammatory response and/or TASS (toxic anterior segment syndrome) in patients following surgery, says AMO.

    AMO received FDA approval for Healon D viscoelastic last month.

    "While AMO has received limited reports, the company elected to proceed aggressively to minimize the potential impact on its customers and their patients and initiated a voluntary recall of the specific lot," says AMO in a prepared statement. "AMO has notified all customers in possession of the specific lot of Healon D viscoelastic, and will be notifying the U.S. Food and Drug Administration (FDA)."

    AMO says it has located and removed from inventory the single lot of Healon D viscoelastic in question. The company adds that all other Healon viscoelastic products are unaffected by this action. Healon D viscoelastic has been available in Europe since July of this year and has not experienced a similar issue, says AMO.

    Dan O’Connor

  • Categories: Product Reports, News
    Already have an account? Please sign in:
    Email Address:
    Password:
    PRODUCT & SERVICE RESOURCES
    Product & Service Showcase
    A showcase of products and services geared to make your facility better.
    Professional Services Platinum Pages
    A guide of people and companies to help make your facility better.
    Other Articles That May Interest You
    Care-Tech Laboratories Suspends Operations Amid FDA Probe
    St. Louis-based company agrees to stop making, selling and distributing unnapproved antimicrobial products.
    Surgeon Groups Oppose Senate Health Reform Legislation
    In letter to Senate leaders, surgeons say proposals would harm quality and access.
    Eye Surgeon and Wife in Murder-Suicide
    Indiana couple had been indicted for Medicare fraud.